BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 29, 2026
Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

Report from Europe: Sanofi readies micro-injection device for influenza vaccines

Jan. 14, 2010
By John Brosky

ICD/CRT use in Europe said to have doubled since 2004

Jan. 1, 2010
By John Brosky

No sign of crisis for medtech evident as Medica turns 40

Jan. 1, 2010
By John Brosky

Report from Europe: French IVD leader wins fresh capital, new management

Dec. 3, 2009
By John Brosky

Report from Europe: ICD/CRT use in Europe said to have doubled since 2004

Dec. 2, 2009
By John Brosky

Competition in ultrasound market reshaping sector

Nov. 30, 2009
By John Brosky
DÜSSELDORF, Germany – The economic downturn that has stalled decisions on capital outlay for the big ticket machines of radiology is benefitting a rapidly shifting market for ultrasound that is expected to grow by 15% each year from almost $3 billion in 2008 to over $5 billion by 2012. (Medical Device Daily)
Read More

Seegene accelerates H1N1 screening with new kits

Nov. 25, 2009
By John Brosky
For influenza testing as the H1N1 virus rises to pandemic levels, there is the first-to-market advantage and then there is, well, not much for all the rest. Moving quickly since guidelines were released by the World Health Organization (WHO) in August, 2009, the Korean company Seegene (Bangyi-Dong, South Korea) was able to present at the Medica trade fair held here last week a real-time, high volume rapid test for the four pathogen assays required by guidelines. (Medical Device Daily)
Read More

Wii for healthcare could take motion game to a new level

Nov. 24, 2009
By John Brosky
DÜSSELDORF, Germany – Motion detecting is more than just fun and games. The technology behind the popular Wii from Nintendo is "pretty lightweight technology," according to Marc Attia who directs sales for Movea (Grenoble), who suggests there is a lot more science, and especially clinically useful information, that can be extracted from monitoring the activities of patients. (Medical Device Daily)
Read More

European product focus advances the expansion of Welch Allyn

Nov. 23, 2009
By John Brosky
DÜSSELDORF, Germany — Just as a great chess game can begin with the advance of a modest pawn, the CEO of Welch Allyn (Skaneateles Falls, New York), Julie Shimer rolled forward the new CP 50, a transportable electrocardiograph (ECG) that represents the leading edge of the company's ambitious plans for international expansion. (Medical Device Daily)
Read More

'Smart' patient monitoring needed to improve workflow, safety issues

Nov. 20, 2009
By John Brosky
View All Articles by John Brosky

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 28, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 28, 2026.
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • Dice spelling out D-E-A-L-?, yes, no

    Muted and missing M&As: JPM deals absent in 2026

    BioWorld
    For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing